Journal
LIFE SCIENCES
Volume 287, Issue -, Pages -Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.lfs.2021.120074
Keywords
Curcumin; Curcumin-galactomannan complex; Curcumagalactomannoside; Inflammation; RNAseq analysis; DEG; In vivo
Funding
- Akay Natural Ingredients, Cochin, India
Ask authors/readers for more resources
The novel curcumagalactomannosides (CGM) have shown higher bioavailability than traditional curcumin, indicating potential for prevention and treatment of chronic diseases. The study revealed significant effects of CGM on the expression of various genes in liver tissues, suggesting its therapeutic benefits for multiple chronic diseases.
Background: Chronic diseases or non-communicable diseases are a major burden worldwide due to the lack of highly efficacious treatment modalities and the serious side effects associated with the available therapies. Purpose/study design: A novel self-emulsifying formulation of curcumin with fenugreek galactomannan hydrogel scaffold as a water-dispersible non-covalent curcumin-galactomannan molecular complex (curcumagalactomannosides, CGM) has shown better bioavailability than curcumin and can be used for the prevention and treatment of chronic diseases. However, the exact potential of this formulation has not been studied, which would pave the way for its use for the prevention and treatment of multiple chronic diseases. Methods: The whole transcriptome analysis (RNAseq) was used to identify differentially expressed genes (DEGs) in the liver tissues of mice treated with LPS to investigate the potential of CGM on the prevention and treatment of chronic diseases. Expression analysis using DESeq2 package, GO, and pathway analysis of the differentially expressed transcripts was performed using UniProtKB and KEGG-KAAS server. Results: The results showed that 559 genes differentially expressed between the liver tissue of control mice and CGM treated mice (100 mg/kg b.wt. for 14 days), with adjusted p-value below 0.05, of which 318 genes were significantly upregulated and 241 were downregulated. Further analysis showed that 33 genes which were upregulated (log2FC > 8) in the disease conditions were significantly downregulated, and 32 genes which were downregulated (log2FC <-8) in the disease conditions were significantly upregulated after the treatment with CGM. Conclusion: Overall, our study showed CGM has high potential in the prevention and treatment of multiple chronic diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available